RUNX1 and acute myeloid leukemia: ,174,175 This would suggest that RUNX1 may limit angiogenesis in some circumstances, and in support, silencing of RUNX1 in acute myeloid leukaemia cells increased VEGFA promoter activity and conditioned media from these cells led to a significant improvement in the in vitro angiogenic capacity of HUVECs.175